TRAP1 and prostate carcinoma: In the case of TRAP1, the majority of human malignancies are characterized by its upregulation (i.e., colorectal, lung, breast and prostate carcinomas), whereas selected tumors by its downregulation (i.e., renal, cervical and ovarian carcinomas) [25].